BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: J. Cheng S, Pratt DS, Freeman RB, Kaplan MM, Wong JB. LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1: . Transplantation 2001;72:861-8. [DOI: 10.1097/00007890-200109150-00021] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Helton WS, Di Bisceglie A, Chari R, Schwartz M, Bruix J. Treatment strategies for hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2003;7:401-11. [PMID: 12654567 DOI: 10.1016/s1091-255x(02)00161-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
2 Man K, Lo CM, Xiao JW, Ng KT, Sun BS, Ng IO, Cheng Q, Sun CK, Fan ST. The Significance of Acute Phase Small-for-Size Graft Injury on Tumor Growth and Invasiveness After Liver Transplantation. Annals of Surgery 2008;247:1049-57. [DOI: 10.1097/sla.0b013e31816ffab6xxx] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
3 Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. The Lancet Oncology 2004;5:409-18. [DOI: 10.1016/s1470-2045(04)01508-6] [Cited by in Crossref: 117] [Cited by in F6Publishing: 44] [Article Influence: 6.5] [Reference Citation Analysis]
4 Cronin DC, Siegler M. Ethics of Living Donor Liver Transplantation. Transplantation of the Liver. Elsevier; 2005. pp. 725-40. [DOI: 10.1016/b978-0-7216-0118-2.50053-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Giannelli G, Antonaci S. New frontiers in biomarkers for hepatocellular carcinoma. Dig Liver Dis 2006;38:854-9. [PMID: 16782417 DOI: 10.1016/j.dld.2006.05.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
6 Yamashiki N, Gaynor JJ, Kato T, Reddy KR, Sobhonslidsuk A, Levi D, Nishida S, Madariaga J, Nery J, Schiff ER. Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma. Am J Transplant. 2004;4:774-781. [PMID: 15084174 DOI: 10.1111/j.1600-6143.2004.00412.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
7 Fan ST. Live donor liver transplantation in adults. Transplantation. 2006;82:723-732. [PMID: 17006315 DOI: 10.1097/01.tp.0000235171.17287.f2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
8 Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience. J Hepatobiliary Pancreat Sci. 2010;17:548-554. [PMID: 19760139 DOI: 10.1007/s00534-009-0165-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2004;10:440-447. [PMID: 15004774 DOI: 10.1002/lt.20097] [Cited by in Crossref: 125] [Cited by in F6Publishing: 105] [Article Influence: 6.9] [Reference Citation Analysis]
10 Abdo AA, Hassanain M, AlJumah A, Al Olayan A, Sanai FM, Alsuhaibani HA, Abdulkareem H, Abdallah K, AlMuaikeel M, Al Saghier M, Babatin M, Kabbani M, Bazarbashi S, Metrakos P, Bruix J; Saudi Association for the Study of Liver Diseases and Transplantation., Saudi Oncology Society. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines. Ann Saudi Med 2012;32:174-99. [PMID: 22366832 DOI: 10.5144/0256-4947.2012.174] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
11 Andreani P, Hoti E, de la Serna S, degli Esposti D, Sebagh M, Lemoine A, Ichai P, Saliba F, Castaing D, Azoulay D. Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance. HPB (Oxford). 2010;12:439-446. [PMID: 20815852 DOI: 10.1111/j.1477-2574.2010.00194.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
12 Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology. 2004;127:S277-S282. [PMID: 15508095 DOI: 10.1053/j.gastro.2004.09.042] [Cited by in Crossref: 132] [Cited by in F6Publishing: 117] [Article Influence: 7.3] [Reference Citation Analysis]
13 Kaihara S, Kiuchi T, Ueda M, Oike F, Fujimoto Y, Ogawa K, Kozaki K, Tanaka K. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation. 2003;75:S37-S40. [PMID: 12589138 DOI: 10.1097/01.tp.0000047029.02806.16] [Cited by in Crossref: 129] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
14 Patt CH, Thuluvath PJ. Role of Liver Transplantation in the Management of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S205-10. [DOI: 10.1016/s1051-0443(07)61788-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(3): 249-254 [DOI: 10.11569/wcjd.v11.i3.249] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Kim SH, Cho SY, Park S, Lee KW, Han S, Lee S, Park J, Kim C. Learning curve for living-donor liver transplantation in a fledgling cancer center. Transplant International 2009;22:1164-71. [DOI: 10.1111/j.1432-2277.2009.00934.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
17 Kaplan DE, Reddy KR. Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes. Clin Liver Dis 2003;7:683-714. [PMID: 14509534 DOI: 10.1016/s1089-3261(03)00060-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
18 Sotiropoulos GC, Lang H, Nadalin S, Neuhäuser M, Molmenti EP, Baba HA, Paul A, Saner FH, Weber F, Hilgard P, Frilling A, Broelsch CE, Malagó M. Liver Transplantation for Hepatocellular Carcinoma: University Hospital Essen Experience and Metaanalysis of Prognostic Factors. Journal of the American College of Surgeons 2007;205:661-75. [DOI: 10.1016/j.jamcollsurg.2007.05.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
19 Roberts JP. Role of adult living liver donation in patients with hepatocellular cancer. Liver Transplantation;9:S60-3. [DOI: 10.1053/jlts.2003.50227] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
20 Maluf D, Fisher RA, Maroney T, Cotterell A, Fulcher A, Tisnado J, Contos M, Luketic V, Stravitz R, Shiffman M. Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy. Am J Transplant. 2003;3:312-317. [PMID: 12614287 DOI: 10.1034/j.1600-6143.2003.00041.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
21 Freeman RB. The impact of the model for end-stage liver disease on recipient selection for adult living liver donation. Liver Transplantation;9:S54-9. [DOI: 10.1053/jlts.2003.50223] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
22 Volk ML, Vijan S, Marrero JA. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant. 2008;8:839-846. [PMID: 18318783 DOI: 10.1111/j.1600-6143.2007.02138.x] [Cited by in Crossref: 135] [Cited by in F6Publishing: 128] [Article Influence: 9.6] [Reference Citation Analysis]
23 Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 2008;43:18-26. [DOI: 10.1007/s00535-007-2141-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
24 Molmenti EP, Klein AS. Liver transplantation for hepatocellular carcinoma: . Current Opinion in Organ Transplantation 2002;7:124-8. [DOI: 10.1097/00075200-200206000-00003] [Reference Citation Analysis]
25 Chui A, Rao A, Island E, Chan H, Leung T, Lau W. Multimodality tumor control and living donor transplantation for unresectable hepatocellular carcinoma. Transplantation Proceedings 2004;36:2287-8. [DOI: 10.1016/j.transproceed.2004.08.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Volk ML, Lok AS, Ubel PA, Vijan S. Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation. Med Decis Making 2008;28:763-72. [PMID: 18725405 DOI: 10.1177/0272989X08316999] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sherman M, Klein A. AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings. Hepatology 2004;40:1465-73. [PMID: 15565604 DOI: 10.1002/hep.20528] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
28 Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, Freeman RB. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl. 2011;17 Suppl 2:S81-S89. [PMID: 21748847 DOI: 10.1002/lt.22380] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
29 Hertl M, Cosimi AB. Liver transplantation for malignancy. Oncologist. 2005;10:269-281. [PMID: 15821247 DOI: 10.1634/theoncologist.10-4-269] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 5.0] [Reference Citation Analysis]
30 Kaido T, Uemoto S. Does living donation have advantages over deceased donation in liver transplantation? J Gastroenterol Hepatol. 2010;25:1598-1603. [PMID: 20880167 DOI: 10.1111/j.1440-1746.2010.06418.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
31 Yao F. Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transplantation 2002;8:765-74. [DOI: 10.1053/jlts.2002.34892] [Cited by in Crossref: 301] [Cited by in F6Publishing: 279] [Article Influence: 15.1] [Reference Citation Analysis]
32 Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology. 2004;127:S277-S282. [PMID: 15508095 DOI: 10.1007/978-1-60327-376-3_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Volk ML, Marrero JA. Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep. 2008;10:60-66. [PMID: 18417044 DOI: 10.1007/s11894-008-0010-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
34 Bremner KE, Bayoumi AM, Sherman M, Krahn MD. Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis. Can J Gastroenterol 2007;21:491-500. [PMID: 17703248 DOI: 10.1155/2007/182383] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
35 Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Yamashita Y, Maehara Y. Liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008;15:124-30. [DOI: 10.1007/s00534-007-1296-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
36 Xiao GQ, Song JL, Shen S, Yang JY, Yan LN. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation. World J Gastroenterol 2014; 20(31): 10953-10959 [PMID: 25152599 DOI: 10.3748/wjg.v20.i31.10953] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
37 de Villa V, Lo CM. Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007;12:1321-1331. [PMID: 18055852 DOI: 10.1634/theoncologist.12-11-1321] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 5.8] [Reference Citation Analysis]
38 Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, Ichai P, Saliba F, Adam R, Castaing D, Azoulay D. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation. Hepatology 2011;53:1570-9. [DOI: 10.1002/hep.24231] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 8.7] [Reference Citation Analysis]
39 Ye YF, Wang W, Wang T, Yu J, Geng L, Yu SF, Yan S, Zheng SS. Role of [18F] fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2017;16:257-263. [PMID: 28603093 DOI: 10.1016/s1499-3872(17)60011-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Lee SD, Kim SH, Kim YK, Kim C, Kim SK, Han SS, Park SJ. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma. Transpl Int. 2013;26:50-60. [PMID: 23106431 DOI: 10.1111/j.1432-2277.2012.01572.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
41 Ilmakunnas M, Höckerstedt K, Mäkisalo H, Siitonen S, Repo H, Pesonen EJ. Hepatic IL-8 release during graft procurement is associated with impaired graft function after human liver transplantation. Clin Transplant 2010;24:29-35. [PMID: 19222504 DOI: 10.1111/j.1399-0012.2009.00975.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
42 Majno P, Giostra E, Mentha G. Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials? Liver Transpl 2007;13:S27-35. [DOI: 10.1002/lt.21328] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
43 Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009;15:148-62. [PMID: 19177435 DOI: 10.1002/lt.21671] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
44 Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Yamashita K, Kamiyama T, Matsushita M, Todo S. Living-donor liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006;13:393-7. [DOI: 10.1007/s00534-005-1079-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
45 Mela M, Mancuso A, Burroughs AK. Review article: hepatocellular carcinoma: indications for liver transplantation. Aliment Pharmacol Ther. 2003;17 Suppl 2:130-137. [PMID: 12786624 DOI: 10.1046/j.1365-2036.17.s2.16.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
46 Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609-1619. [PMID: 12016426 DOI: 10.1053/gast.2002.33411] [Cited by in Crossref: 374] [Cited by in F6Publishing: 363] [Article Influence: 18.7] [Reference Citation Analysis]
47 Lee SG, Moon DB. Living donor liver transplantation for hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:165-179. [PMID: 22941020 DOI: 10.1007/978-3-642-16037-0_11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
48 Fan ST. Live-donor liver transplantation for hepatocellular carcinoma. Hepatol Res 2007;37 Suppl 2:S275-6. [PMID: 17877494 DOI: 10.1111/j.1872-034X.2007.00196.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy? Ann Surg. 2003;238:508-18; discussion 518-9. [PMID: 14530722 DOI: 10.1097/01.sla.0000090449.87109.44] [Cited by in Crossref: 66] [Cited by in F6Publishing: 131] [Article Influence: 3.5] [Reference Citation Analysis]
50 Majno P, Giostra E, Morel P, Hadengue A, Mentha G. Management of hepatocellular carcinoma in the waiting list before liver transplantation. Journal of Hepatology 2005;42:S134-43. [DOI: 10.1016/j.jhep.2004.12.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
51 Concejero A, Chen CL, Wang CC, Wang SH, Lin CC, Liu YW, Yang CH, Yong CC, Lin TS, Jawan B, Huang TL, Cheng YF, Eng HL. Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan. Transplantation 2008;85:398-406. [PMID: 18322432 DOI: 10.1097/TP.0b013e3181622ff8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
52 Cheng S. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transplantation 2002;8:323-8. [DOI: 10.1053/jlts.2002.31749] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 3.2] [Reference Citation Analysis]
53 Akhtar M, Henderson T, Sutherland A, Vogel T, Friend P. Novel Approaches to Preventing Ischemia-Reperfusion Injury During Liver Transplantation. Transplantation Proceedings 2013;45:2083-92. [DOI: 10.1016/j.transproceed.2013.04.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
54 Koteish A, Thuluvath PJ. Screening for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2002;13:S185-90. [DOI: 10.1016/s1051-0443(07)61785-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
55 Morris-stiff G, Gomez D, de Liguori Carino N, Prasad K. Surgical management of hepatocellular carcinoma: Is the jury still out? Surgical Oncology 2009;18:298-321. [DOI: 10.1016/j.suronc.2008.08.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
56 Cha C, DeMatteo RP, Blumgart LH. Surgery and ablative therapy for hepatocellular carcinoma. J Clin Gastroenterol. 2002;35:S130-S137. [PMID: 12449982 DOI: 10.1097/00004836-200211002-00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
57 Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002;8:873-883. [PMID: 12360427 DOI: 10.1053/jlts.2002.34923] [Cited by in Crossref: 291] [Cited by in F6Publishing: 279] [Article Influence: 15.3] [Reference Citation Analysis]
58 Berg CL, Gillespie BW, Merion RM, Brown RS, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology. 2007;133:1806-1813. [PMID: 18054553 DOI: 10.1053/j.gastro.2007.09.004] [Cited by in Crossref: 142] [Cited by in F6Publishing: 115] [Article Influence: 9.5] [Reference Citation Analysis]
59 Pérez Saborido B, Meneu JC, Moreno E, García I, Moreno A, Fundora Y. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg. 2005;190:383-387. [PMID: 16105523 DOI: 10.1016/j.amjsurg.2005.06.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
60 Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg. 2007;94:78-86. [PMID: 17016793 DOI: 10.1002/bjs.5528] [Cited by in Crossref: 159] [Cited by in F6Publishing: 157] [Article Influence: 10.6] [Reference Citation Analysis]
61 Volk ML, Marrero JA, Lok AS, Ubel PA. Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma. Transplantation 2006;82:1136-9. [PMID: 17102762 DOI: 10.1097/01.tp.0000245670.75583.3d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
62 Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Transplantation. 2014;97:71-77. [PMID: 24056623 DOI: 10.1097/tp.0b013e3182a68953] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
63 Chen C, Concejero AM. Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:555-8. [DOI: 10.1007/s00534-009-0166-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
64 Tanwar S, Khan SA, Grover VPB, Gwilt C, Smith B, Brown A. Liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2009; 15(44): 5511-5516 [PMID: 19938188 DOI: 10.3748/wjg.15.5511] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
65 Al Sibae MR, Cappell MS. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig Dis Sci. 2011;56:977-987. [PMID: 20844956 DOI: 10.1007/s10620-010-1390-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
66 Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology. 2004;127:S261-S267. [PMID: 15508092 DOI: 10.1053/j.gastro.2004.09.040] [Cited by in Crossref: 208] [Cited by in F6Publishing: 174] [Article Influence: 11.6] [Reference Citation Analysis]
67 Ravaioli M, Ercolani G, Cescon M, Vetrone G, Voci C, Grigioni WF, D'errico A, Ballardini G, Cavallari A, Grazi GL. Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria. Liver Transpl 2004;10:1195-202. [DOI: 10.1002/lt.20239] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 4.1] [Reference Citation Analysis]
68 Abbasoglu O. Liver transplantation: Yesterday, today and tomorrow. World J Gastroenterol 2008; 14(20): 3117-3122 [PMID: 18506914 DOI: 10.3748/wjg.14.3117] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
69 Song GW, Lee SG, Hwang S, Sung GB, Park KM, Kim KH, Ahn CS, Moon DB, Ha TY, Kim BS, Moon KM, Jung DH. Preoperative evaluation of biliary anatomy of donor in living donor liver transplantation by conventional nonenhanced magnetic resonance cholangiography. Transpl Int. 2007;20:167-173. [PMID: 17239025 DOI: 10.1111/j.1432-2277.2006.00419.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
70 Nijboer WN, Schuurs TA, van der Hoeven JAB, Ploeg RJ. Effect of brain death and donor treatment on organ inflammatory response and donor organ viability: . Current Opinion in Organ Transplantation 2004;9:110-5. [DOI: 10.1097/01.mot.0000127632.16121.a9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
71 Shih KC, Man K. Small-for-size liver graft injury--impact on tumor behavior. Transplant Rev (Orlando). 2010;24:1-10. [PMID: 19828306 DOI: 10.1016/j.trre.2009.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
72 Tsoulfas G, Agorastou P, Tooulias A, Marakis GN. Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review. Int Surg 2014;99:779-86. [PMID: 25437587 DOI: 10.9738/INTSURG-D-13-00122.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
73 Doğan SM, Kutlutürk K. Living Donor Versus Deceased Donor Liver Transplantation for HCC. J Gastrointest Cancer 2020;51:1104-6. [PMID: 32833221 DOI: 10.1007/s12029-020-00481-1] [Reference Citation Analysis]
74 Earl TM, Chapman WC. Transplantation for hepatocellular carcinoma: the North American experience. Recent Results Cancer Res 2013;190:145-64. [PMID: 22941019 DOI: 10.1007/978-3-642-16037-0_10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
75 Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2005;3:75-84. [PMID: 15645408 DOI: 10.1016/s1542-3565(04)00443-4] [Cited by in Crossref: 65] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
76 Freeman RB. Transplantation for hepatocellular carcinoma: The Milan criteria and beyond. Liver Transpl. 2006;12:S8-13. [PMID: 17051567 DOI: 10.1002/lt.20936] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
77 Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology. 2011;54:1313-1321. [PMID: 21688284 DOI: 10.1002/hep.24494] [Cited by in Crossref: 98] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]